Acinetobacter baumannii infection inhibits airway eosinophilia and lung pathology in a mouse model of allergic asthma

PLoS ONE

Volumn 6, Issue 7, 2011, Pages

  Qiu, Hongyu ^a,c   KuoLee, Rhonda ^a   Harris, Greg ^a   Zhou, Hongyan ^a   Miller, Harvey ^a   Patel, Girishchandra B ^a   Chen, Wangxue ^a,b  

^a NATIONAL RESEARCH COUNCIL CANADA   (Canada)

^b BROCK UNIVERSITY   (Canada)

^c Cangene Corporation   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CYTOKINE; GAMMA INTERFERON; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; OVALBUMIN; TOLL LIKE RECEPTOR 4; IMMUNOGLOBULIN G; TLR4 PROTEIN, MOUSE;

ACINETOBACTER INFECTION; ALLERGIC ASTHMA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RESPONSE; DISEASE MODEL; EOSINOPHIL COUNT; EOSINOPHILIA; FEMALE; IMMUNE DYSREGULATION; IMMUNOMODULATION; IN VITRO STUDY; INNATE IMMUNITY; LUNG LAVAGE; LYMPH NODE CELL; MOUSE; MUCUS SECRETION; NONHUMAN; PATHOPHYSIOLOGY; PROVOCATION TEST; REGULATORY T LYMPHOCYTE; TH1 CELL; TH2 CELL; ACINETOBACTER BAUMANNII; ANIMAL; ASTHMA; BLOOD; C57BL MOUSE; IMMUNIZATION; IMMUNOLOGY; INTRANASAL DRUG ADMINISTRATION; LUNG; METABOLISM; MICROBIAL VIABILITY; MICROBIOLOGY; PATHOLOGY;

ACINETOBACTER BAUMANNII; MUS;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ADMINISTRATION, INTRANASAL; ANIMALS; ASTHMA; CHEMOKINES; DISEASE MODELS, ANIMAL; EOSINOPHILIA; FEMALE; IMMUNIZATION; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; INTERFERON-GAMMA; LUNG; MICE; MICE, INBRED C57BL; MICROBIAL VIABILITY; OVALBUMIN; T-LYMPHOCYTES, REGULATORY; TOLL-LIKE RECEPTOR 4;

EID: 79960583159     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0022004     Document Type: Article

References (52)

1. Lazaar AL, Panettieri RA, (2004) Pathogenesis and treatment of asthma: recent advances. Drug Discov Today: Dis Mech 1: 111-116.
2. Galli SJ, Tsai M, Piliponsky AM, (2008) The development of allergic inflammation. Nature 454: 445-454.
3. Lukacs NW, (2001) Role of chemokines in the pathogenesis of asthma. Nat Rev Immunol 1: 108-116.
4. Nauta AJ, Engels F, Knippels LM, Garssen J, Nijkamp FP, et al. (2008) Mechanisms of allergy and asthma. Eur J Pharmacol 585: 354-360.
5. Yazdanbakhsh M, Kremsner PG, van Ree R, (2002) Allergy, Parasites, and the Hygiene Hypothesis. Science 296: 490-494.
6. Finn PW, Bigby TD, (2009) Innate Immunity and Asthma. Proc Am Thorac Soc 6: 260-265.
7. Strachan DP, (1989) Hay fever, Hygiene, and household size. BMJ 299: 1259-1260.
8. Erb KJ, Holloway JW, Sobeck A, Moll H, Le Gros G, (1998) Infection of Mice with Mycobacterium bovis-Bacillus Calmette-Guerin (BCG) Suppresses Allergen-induced Airway Eosinophilia. J Exp Med 187: 561-569.
9. Matricardi PM, Bjorksten B, Bonini S, Bousquet J, Djukanovic R, et al. (2003) Microbial products in allergy prevention and therapy. Allergy 58: 461-471.
10. Hansen G, Yeung VP, Berry G, Umetsu DT, DeKruyff RH, (2000) Vaccination with Heat-Killed Listeria as Adjuvant Reverses Established Allergen-Induced Airway Hyperreactivity and Inflammation: Role of CD8+ T Cells and IL-18. J Immunol 164: 223-230.
11. Kline JN, Kitagaki K, Businga TR, Jain VV, (2002) Treatment of established asthma in a murine model using CpG oligodeoxynucleotides. Am J Physiol Lung Cell Mol Physiol 283: L170-179.
12. Smit JJ, Van Loveren H, Hoekstra MO, Van der Kant PAA, Folkerts G, et al. (2003) Therapeutic treatment with heat-killed Mycobacterium vaccae (SRL172) in a mild and severe mouse model for allergic asthma. Eur J Pharmacol 470: 193-199.
13. Jain VV, Businga TR, Kitagaki K, George CL, O'Shaughnessy PT, et al. (2003) Mucosal immunotherapy with CpG oligodeoxynucleotides reverses a murine model of chronic asthma induced by repeated antigen exposure. Am J Physiol Lung Cell Mol Physiol 285: L1137-1146.
14. Sayers I, Severn W, Scanga CB, Hudson J, Gros GL, et al. (2004) Suppression of allergic airway disease using mycobacterial lipoglycans. J Allergy Clin Immunol 114: 302-309.
15. Rodriguez D, Keller AC, Faquim-Mauro EL, de Macedo MS, Cunha FQ, et al. (2003) Bacterial Lipopolysaccharide Signaling Through Toll-Like Receptor 4 Suppresses Asthma-Like Responses Via Nitric Oxide Synthase 2 Activity. J Immunol 171: 1001-1008.
16. Wohlleben G, Muller J, Tatsch U, Hambrecht C, Herz U, et al. (2003) Influenza A Virus Infection Inhibits the Efficient Recruitment of Th2 Cells into the Airways and the Development of Airway Eosinophilia. J Immunol 170: 4601-4611.
17. KuoLee R, Zhou H, Harris G, Zhao X, Qiu H, et al. (2008) Inhibition of airway eosinophilia and pulmonary pathology in a mouse model of allergic asthma by the live vaccine strain of Francisella tularensis. Clin Exp Allergy 38: 1003-1015.
18. Dijkshoorn L, Nemec A, Seifert H, (2007) An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii. Nat Rev Micro 5: 939-951.
19. Knapp S, Wieland CW, Florquin S, Pantophlet R, Dijkshoorn L, et al. (2006) Differential Roles of CD14 and Toll-like Receptors 4and 2 in Murine Acinetobacter Pneumonia. Am J Respir Crit Care Med 173: 122-129.
20. van Faassen H, KuoLee R, Harris G, Zhao X, Conlan JW, et al. (2007) Neutrophils Play an Important Role in Host Resistance to Respiratory Infection with Acinetobacter baumannii in Mice. Infect Immun 75: 5597-5608.
21. Careau E, Bissonnette EY, (2004) Adoptive Transfer of Alveolar Macrophages Abrogates Bronchial Hyperresponsiveness. Am J Respir Cell Mol Biol 31: 22-27.
22. Rozen S, Skaletsky H, (2000) Primer3 on the WWW for general users and for biologist programmers. Methods Mol Biol 132: 365-386.
23. KuoLee R, Zhao X, Austin J, Harris G, Conlan JW, et al. (2007) Mouse model of oral infection with virulent type A Francisella tularensis. Infect Immun 75: 1651-1660.
24. Chen W, Havell EA, Moldawer LL, McIntyre KW, Chizzonite RA, et al. (1992) Interleukin 1: an important mediator of host resistance against Pneumocystis carinii. J Exp Med 176: 713-718.
25. Preston JA, Essilfie A-T, Horvat JC, Wade MA, Beagley KW, et al. (2007) Inhibition of allergic airways disease by immunomodulatory therapy with whole killed Streptococcus pneumoniae. Vaccine 25: 8154-8162.
26. Young-SukKim, Keun-SangKwon, Dae-KiKim, Il-WhanChoi, Hern-KuLee, (2004) Inhibition of murine allergic airway disease by Bordetella pertussis. Immunology 112: 624-630.
27. Ennis DP, Cassidy JP, Mahon BP, (2005) Whole-cell pertussis vaccine protects against Bordetella pertussis exacerbation of allergic asthma. Immunol Letters 97: 91-100.
28. Garcia-Zepeda EA, Rothenberg ME, Ownbey RT, Celestin J, Leder P, et al. (1996) Human eotaxin is a specific chemoattractant for eosinophil cells and provides a new mechanism to explain tissue eosinophilia. Nat Med 2: 449-456.
29. Ballantyne SJ, Barlow JL, Jolin HE, Nath P, Williams AS, et al. (2007) Blocking IL-25 prevents airway hyperresponsiveness in allergic asthma. J Allergy Clin Immunol 120: 1324-1331.
30. Mould AW, Ramsay AJ, Matthaei KI, Young IG, Rothenberg ME, et al. (2000) The Effect of IL-5 and Eotaxin Expression in the Lung on Eosinophil Trafficking and Degranulation and the Induction of Bronchial Hyperreactivity. J Immunol 164: 2142-2150.
31. Gonzalo JA, Lloyd CM, Kremer L, Finger E, Martinez AC, et al. (1996) Eosinophil recruitment to the lung in a murine model of allergic inflammation. The role of T cells, chemokines, and adhesion receptors. J Clin Invest 98: 2332-2345.
32. Pease JE, Williams TJ, (2001) Eotaxin and asthma. Curr Opin Pharmacol 1: 248-253.
33. Pope SM, Zimmermann N, Stringer KF, Karow ML, Rothenberg ME, (2005) The Eotaxin Chemokines and CCR3 Are Fundamental Regulators of Allergen-Induced Pulmonary Eosinophilia. J Immunol 175: 5341-5350.
34. Pope SM, Fulkerson PC, Blanchard C, Akei HS, Nikolaidis NM, et al. (2005) Identification of a Cooperative Mechanism Involving Interleukin-13 and Eotaxin-2 in Experimental Allergic Lung Inflammation. J Biol Chem 280: 13952-13961.
35. Ponath PD, Qin S, Ringler DJ, Clark-Lewis I, Wang J, et al. (1996) Cloning of the human eosinophil chemoattractant, eotaxin. Expression, receptor binding, and functional properties suggest a mechanism for the selective recruitment of eosinophils. J Clin Invest 97: 604-612.
36. MacLean LL, Perry MB, Chen W, Vinogradov E, (2009) The structure of the polysaccharide O-chain of the LPS from Acinetobacter baumannii strain ATCC 17961. Carbohydr Res 344: 474-478.
37. Wang Y, McCusker C, (2006) Neonatal exposure with LPS and/or allergen prevents experimental allergic airways disease: development of tolerance using environmental antigens. J Allergy Clin Immunol 118: 143-151.
38. Hollingsworth JW, Whitehead GS, Lin KL, Nakano H, Gunn MD, et al. (2006) TLR4 Signaling Attenuates Ongoing Allergic Inflammation. J Immunol 176: 5856-5862.
39. Gavett S, O'Hearn D, Li X, Huang S, Finkelman F, et al. (1995) Interleukin 12 inhibits antigen-induced airway hyperresponsiveness, inflammation, and Th2 cytokine expression in mice. J Exp Med 182: 1527-1536.
40. Nakagome K, Okunishi K, Imamura M, Harada H, Matsumoto T, et al. (2009) IFN-g Attenuates Antigen-Induced Overall Immune Response in the Airway As a Th1-Type Immune Regulatory Cytokine. J Immunol 183: 209-220.
41. Yoshida M, Leigh R, Matsumoto K, Wattie J, Ellis R, et al. (2002) Effect of Interferon-γ on Allergic Airway Responses in Interferon-{gamma}-deficient Mice. Am J Respir Crit Care Med 166: 451-456.
42. Zuany-Amorim C, Sawicka E, Manlius C, Le Moine A, Brunet LR, et al. (2002) Suppression of airway eosinophilia by killed Mycobacterium vaccae-induced allergen-specific regulatory T-cells. Nat Med 8: 625-629.
43. Preston JA, Thorburn AN, Starkey MR, Beckett EL, Horvat JC, et al. (2011) Streptococcus pneumoniae infection suppresses allergic airways disease by inducing regulatory T-cells. Eur Respir J 37: 53-64.
44. Gaynes R, Edwards JR, (2005) Overview of nosocomial infections caused by gram-negative bacilli. Clin Infect Dis 41: 848-854.
45. Joly-Guillou ML, (2005) Clinical impact and pathogenicity of Acinetobacter. Clin Microbiol Infect 11: 868-873.
46. Peleg AY, Seifert H, Paterson DL, (2008) Acinetobacter baumannii: Emergence of a Successful Pathogen. Clin Microbiol Rev 21: 538-582.
47. Fournier PE, Richet H, (2006) The epidemiology and control of Acinetobacter baumannii in health care facilities. Clin Infect Dis 42: 692-699.
48. Han X, Fan Y, Wang S, Yang J, Bilenki L, et al. (2004) Dendritic cells from Chlamydia-infected mice show altered Toll-like receptor expression and play a crucial role in inhibition of allergic responses to ovalbumin. Eur J Immunol 34: 981-989.
49. Debarry J, Garn H, Hanuszkiewicz A, Dickgreber N, Blümer N, et al. (2007) Acinetobacter lwoffii and Lactococcus lactis strains isolated from farm cowsheds possess strong allergy-protective properties. J Allergy Clin Immunol 119: 1514-1521.
50. von Mutius E, Braun-Fahrlander C, Schierl R, Riedler J, Ehlermann S, et al. (2000) Exposure to endotoxin or other bacterial components might protect against the development of atopy. Clin Exp Allergy 30: 1230-1234.
51. Michel O, (2003) Role of lipopolysaccharide (LPS) in asthma and other pulmonary conditions. J Endotoxin Res 9: 293-300.
52. Smani Y, Docobo-Pérez F, McConnell MJ, Pachón J, (2011) Acinetobacter baumannii-induced lung cell death: Role of inflammation, oxidative stress and cytosolic calcium. Microb Pathog 50: 224-232.